1 / 9

JSB Market Research - Epilepsy Therapeutics in Major Develop

"Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns", which provides in-depth analysis of epilepsy market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada.

MarrissaV
Download Presentation

JSB Market Research - Epilepsy Therapeutics in Major Develop

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns

  2. Summary • "Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns", which provides in-depth analysis of epilepsy market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of the market size for 2012, along with market forecasts to 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis.The value of the epilepsy market in the major developed markets amounted to an estimated $3.4 billion in 2012 and is expected to register a Compound Annual Growth Rate (CAGR) of 3.9% to reach $4.5 billion by 2019. This modest growth is attributed to the recent approval of drugs with novel mechanisms of action that are expected to offer more therapeutic options to prescribers. The US takes major share of 55% of the global epilepsy market

  3. Scope • A brief introduction to epilepsy, including disease pathogenesis, risk factors, diagnosis and treatment options • In-depth analysis of major marketed products covering product performance, product life-cycle and a heat map depicting comparative analysis of safety and efficacy parameters • A comprehensive review of the epilepsy pipeline which includes individual analysis of promising late-stage pipeline drugs that are most likely to enter the market during the forecast period. The pipeline is analyzed on the basis of Phase distribution, molecule type and molecular target • Additional clinical trial analysis by Phase, trial size, trial duration and program failure rate for each molecule type and mechanism of action- Multi-scenario forecasts of the epilepsy market over the 20122019 period in the eight major developed markets 

  4. Reasons to buy • Align your product portfolio to markets with high growth potential • Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth • Devise effective, tailored strategies for each country through the understanding of key drivers and barriers in the anti-epileptic drugs market • Develop key strategic initiatives based upon an understanding of key focus areas and leading companies • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships • Check Full Report on : http://www.jsbmarketresearch.com/healthcare-medical/r-Epilepsy-Therapeutics-in-Major-Developed-Markets-107542

  5. Epilepsy Therapeutics in Major Developed Markets to 2019

  6. Related Market Research Report • Allergy Drugs Markets in China • Arthritis Treatment Drugs Markets in China • Asthma Treatment Drugs Markets in China • Diabetes Drugs Markets in China • Pain and Fever Relief Drugs Markets in China • Cough Drugs Markets in China

  7. About JSB Market Research • Jsbmarketresearch.com is an online repository of an extensive collection of market research reports available online. This online portal contains high-quality reports with well-researched and high-quality content on a wide range of industries. These market research reports help us give a detailed insight into new opportunities in the industry, prevailing market trends, competitor analysis and future prospects. • JSB’s reports are developed by the domain experts and publishers under a closely observed surveillance of industry specialists. Therefore, the researched data is well researched, well- organized and matching up to the best standards in the industry. Also JSB’s database consists of detailed insights of the leading players in the global market, products and trends.

  8. Contact Us Support & General Inquiries Mail :support@jsbmarketresearch.com+91 - 998 729 5242 Billing Support Mail :billing@jsbmarketresearch.com+91 22 412 366 50 Websitehttp://www.jsbmarketresearch.com

More Related